Skip to main content
  • Home
  • Articles
    • Archive from 2022 July
    • Archive 1960 to 2022 June
    • Accepted Articles
    • Published Ahead-of-Print
    • Supplement
  • About
  • For Authors
  • Podcasts

Malignant pancreatic carcinoid tumour

< Back to Listing

Share this Article

Singapore Med J 2007; 48(12): e320-e322
Malignant pancreatic carcinoid tumour

  • Abstract
  • PDF

Zarina AL, Hamidah A, Zulkifli SZ, Zulfiqar MA, Jamal R
Correspondence: Dr Zarina A Latiff, zarinaal@mail.hukm.ukm.my

ABSTRACT
Pancreatic carcinoid tumours are rare, particularly within the paediatric population. The clinical presentation is largely dependent on the functionality of the tumour. Although the tumour is generally slow-growing, surgical resection is still the mainstay of curative treatment. Morbidity is, however, significantly contributed by secretion of excess hormones; in view of this, biotherapy is an important treatment strategy. Octreotide, a somatostatin analogue, has been shown to be successful in both symptomatic control and stability of tumour progression. We report a 12-year-old girl, who presented with hypertensive crisis, and showed good response to a combination of chemotherapy and octreotide.

Keywords: carcinoid tumours, paediatric neoplasm, pancreatic carcinoid tumour
Singapore Med J 2007; 48(12): e320–e322

http://smj.org.sg/sites/default/files/4812/4812cr4.pdf
×

Around the Site

Home

About SMJ

For Reviewers

Sign Up for Alerts

Issues

Current Issue

All Issues

Online First

Supplement

CME

For Authors

Instructions for Authors

Submit Manuscript


Follow us on:
        

More Links

Contact Us

Copyright

Advertise

SMJ Forms

Privacy Policy

SMA Home

Copyright 2021. Singapore Medical Association. All Rights Reserved.